Dr.Cash
A company made up of people who understand clients' needs and who will make the credit-to-payment process as simple as possible.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A Valuation: BRL175m 3.9x EV/Revenue | Early VC | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 218 % | 55 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Dr.Cash, founded in 2019 and headquartered in São Paulo, Brazil, operates as a financial services platform specializing in credit for healthcare procedures. The company was established to democratize access to health services by offering financing solutions for medical, dental, and aesthetic treatments. The fintech was co-founded by Gabriel Meireles.
The company's business model is primarily B2B2C, where it partners with clinics and healthcare professionals to offer its financing solutions directly to patients as a payment option. This model helps clinics increase procedure conversions and patient access to treatments of varying costs. For patients, Dr.Cash provides an alternative to using credit card limits, offering installment plans of up to 24 months with interest rates starting from 2.9% per month. Funding for the loans is provided by partner financial institutions, such as Banco BV, with Dr.Cash managing the credit origination and portfolio.
The platform allows patients to apply for financing directly at the partner clinic. After choosing an installment plan and providing the necessary documents, an agreement is sent for approval. Dr.Cash has established partnerships with over 4,000 clinics, including major dental networks like OdontoCompany, Oral Sim, and Sorridents. This B2B2C approach enables clinics to serve more patients and increase revenue, with some partners reporting significant growth in procedures performed.
Dr.Cash has secured funding to support its growth, including a Series A round led by Banco BV's corporate venture capital arm in late 2022, which valued the company at R$175 million (post-money). This capital is being used to enhance its technology, refine its product, and expand its distribution channels. The company is developing its own application to directly attract new customers and provide them with a catalog of accredited clinics, shifting from a purely clinic-based origination model to also include direct-to-consumer outreach.
Keywords: healthcare financing, patient financing, medical credit, dental loans, aesthetic procedure financing, fintech, B2B2C financial services, credit origination, point-of-sale financing, installment payments, Brazil healthcare market, healthcare affordability, clinic payment solutions, Banco BV partnership, Gabriel Meireles, OdontoCompany, financial software, specialized finance